BFG
TAK icon

Bleakley Financial Group’s Takeda Pharmaceutical TAK Stock Holding History

Bleakley Financial Group’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.94M Buy
432,956
+1,354
+0.3% +$22.4K 0.09% 180
2026
Q1 		$7.99M Buy
431,602
+68,844
+19% +$1.21M 0.13% 135
2025
Q4 		$5.66M Buy
362,758
+449
+0.1% +$6.42K 0.1% 171
2025
Q3 		$5.3M Buy
362,309
+2,943
+0.8% +$43.7K 0.12% 146
2025
Q2 		$5.56M Buy
359,366
+32,794
+10% +$485K 0.14% 137
2025
Q1 		$4.86M Buy
326,572
+8,232
+3% +$115K 0.16% 129
2024
Q4 		$4.21M Sell
318,340
-16,830
-5% -$231K 0.13% 141
2024
Q3 		$4.77M Buy
335,170
+35,186
+12% +$499K 0.15% 118
2024
Q2 		$3.88M Buy
299,984
+11,449
+4% +$152K 0.11% 172
2024
Q1 		$4.01M Buy
288,535
+46,182
+19% +$672K 0.12% 175
2023
Q4 		$3.46M Buy
242,353
+28,838
+14% +$409K 0.11% 177
2023
Q3 		$3.3M Buy
213,515
+738
+0.3% +$11.4K 0.12% 165
2023
Q2 		$3.34M Buy
212,777
+17,432
+9% +$286K 0.1% 174
2023
Q1 		$3.22M Sell
195,345
-6,814
-3% -$109K 0.11% 177
2022
Q4 		$3.15M Buy
+202,159
New +$2.82M 0.11% 169

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bleakley Financial Group's TAK Position: Q2 2026 in Review

Bleakley Financial Group increased its Takeda Pharmaceutical (TAK) stake by 0.31% in Q2 2026, buying an estimated $22.4K and bringing the position to 432,956 shares worth $6.94M. The position accounts for 0.09% of the portfolio, ranked #180.

Bleakley Financial Group first reported a position in TAK in Q4 2022 and has held it in 15 quarters since. The position peaked at $7.99M in Q1 2026. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

  • Bleakley Financial Group held 432,956 shares of Takeda Pharmaceutical worth $6.94M as of Q2 2026.
  • Bleakley Financial Group bought 1,354 Takeda Pharmaceutical shares in Q2 2026, an estimated $22.4K.
  • Takeda Pharmaceutical made up 0.09% of Bleakley Financial Group's portfolio in Q2 2026, its #180 holding.
  • Bleakley Financial Group first reported a position in Takeda Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Bleakley Financial Group's Takeda Pharmaceutical position peaked at $7.99M in Q1 2026.
  • 376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.